$16.2M in Funding For Canadian Genome Centres
Genome Canada has announced plans to provide McGill University and Génome Québec Innovation Centre (MUGQIC), the Canadian Centre for Computational Genomics (C3G), and the Centre for Advanced Proteomic Analyses (CAPA) with $19.6M (£11.1M) of funding over the next five years. The plan was unveiled yesterday in joint press releases from Génome Québec and McGill.
The grants, called the Genomics Technology Platforms Operations Support and Technology Development Funds, are designed to support the centres through their on-going research. This not only means enabling them to continue to provide their services to researchers needing their expertise, but also encouraging them to develop novel genomic technologies.
MUGQIC works to bring effective, efficient genomic technologies to Canadian researchers, particular for use in studying chronic or rare diseases, aging, cancer, and environmental impact on genetics. Their work also includes some agricultural applications. The centre is led by Mark Lathrop, PhD, a Professor in the Department of Human Genetics at McGill.
C3G is led by Guillaume Bourque, PhD, and Associate Professor in the Department of Human Genetics at McGill, and Michael Brudno, a Professor at the University of Toronto and Director of the Centre for Computational Medicine at SickKids. The team provide informatics and analysis to the research community, both within Canada and internationally. Since the Centre was established, it has supported 1,014 completed projects from over 600 different research groups.
CAPA is research and core facility that forms part of the Université de Montréal and the Institute for Research in Immunology and Cancer. Their research is largely concerned with protein chemistry, systems biology, and bioanalytical mass spectrometry. The centre is run by Pierre Thibault, PhD, and Michael Tyers, PhD.
Genome Canada is a non-profit organisation established and funded by the Canadian Government. The goal of the organisation is to use government funding to support and develop genomic technologies and applications in such a way as to create societal and economic benefits for the Canadian population. It is hope that this new funding will enable these three Centres of Excellence to continue providing researchers with the support they need and to help push the industry forwards.